Today, the Davidsons are co-founders of Creative BioTherapeutics LLC (CBT), a startup built around a biologic therapy they ...

HCW Biologics earned upfront payment and will recognize revenue of $7.0 million in Q2 2025MIRAMAR, Fla., June 04, 2025 (GLOBE ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

In recent years, overweight and obesity have become a serious global health problem, posing significant risk factors for ...

and WY Biotech Co., Ltd., a China-based company specializing in the early-stage development of recombinant protein drugs and gene/cell therapies, announced today that they have entered into a ...

A protein that gives fleas their bounce has been used to boot out bacteria cells, with lab results demonstrating the material ...

The global protein expression technology market is expected to be reach USD 3,011.8 million in 2025 and is likely to expand ...

Nuclera (Cambridge, UK) is a biotech company that specializes in rapid protein expression and purification optimization at the benchtop. With the aim of streamlining the drug discovery process, ...

HCW Biologics and WY Biotech Co., Ltd., a China-based company specializing in the early-stage development of recombinant protein drugs and gene/cell therapies, have entered into a worldwide ...

The protein drug combines alpha-1 proteins and an antibody ... More information: Mark L. Brantly et al, Recombinant Alpha-1 Antitrypsin–Fc Fusion Protein INBRX-101 in Adults With Alpha-1 ...